Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model

BACKGROUND: Novel therapies capable of targeting drug resistant clonogenic MM cells are required for more effective treatment of multiple myeloma. This study investigates the cytotoxicity of natural killer cell lines against bulk and clonogenic multiple myeloma and evaluates the tumor burden after N...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Swift, Brenna E., Williams, Brent A., Kosaka, Yoko, Wang, Xing-Hua, Medin, Jeffrey A., Viswanathan, Sowmya, Martinez-Lopez, Joaquin, Keating, Armand
Format: Artigo
Langue:Inglês
Publié: Ferrata Storti Foundation 2012
Sujets:
Original Articles and Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396673/
https://ncbi.nlm.nih.gov/pubmed/22271890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.054254
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires